A 28-days sub-acute toxicity study in swiss albino mice to evaluate toxicity profile of neurotol plus (mannitol and glycerol combination)
- PMID: 23675168
- PMCID: PMC3614800
A 28-days sub-acute toxicity study in swiss albino mice to evaluate toxicity profile of neurotol plus (mannitol and glycerol combination)
Abstract
Osmotic agents are still the most common treatment options available for controlling intracranial pressure (ICP). Combining Mannitol and Glycerol provides a better alternative and is currently available as best therapy used for increased ICP. The aim of this work was to study the effects of repeated dosing (28 days) of Mannitol 20% and Glycerol 10% combined formulation, Neurotol plus on safety profile. A twenty eight days sub-acute toxicity study was conducted at three different dose levels of 5ml/kg, 10 ml/kg and 20 ml/kg. Mice were randomly divided into four groups of six animals each. Physical parameters, biochemical parameters related to liver toxicity & nephrotoxicity and hematological parameters were studied as end point of evaluation. We also carried out histopathlogical studies to assess any organ specific toxicity. The present study demonstrated that there were either no or very minimal changes (at high dose) were observed on various physical, biochemical and hematological parameters between Neurotol plus and control group. In conclusion the data of present study suggest that the combination of Mannitol and Glycerol is not associated with any serious adverse effects and is safe therapeutic choice for ICP reduction.
Keywords: glycerol; intracranial pressure; mannitol; neurotol plus; repeated dose toxicity.
Similar articles
-
A Comparative Study of Bolus Dose of Hypertonic Saline, Mannitol, and Mannitol Plus Glycerol Combination in Patients with Severe Traumatic Brain Injury.World Neurosurg. 2019 May;125:e221-e228. doi: 10.1016/j.wneu.2019.01.051. Epub 2019 Jan 24. World Neurosurg. 2019. PMID: 30684710 Clinical Trial.
-
Comparison of different osmotic therapies in a mouse model of traumatic brain injury.Pharmacol Rep. 2017 Feb;69(1):176-184. doi: 10.1016/j.pharep.2016.10.007. Epub 2016 Oct 11. Pharmacol Rep. 2017. PMID: 27923162
-
Osmotherapy for increased intracranial pressure: comparison between mannitol and glycerol.Acta Neurochir (Wien). 1997;139(8):725-32; discussion 732-3. doi: 10.1007/BF01420045. Acta Neurochir (Wien). 1997. PMID: 9309287 Clinical Trial.
-
Glycerol Infusion Versus Mannitol for Cerebral Edema: A Systematic Review and Meta-analysis.Clin Ther. 2021 Mar;43(3):637-649. doi: 10.1016/j.clinthera.2021.01.010. Epub 2021 Feb 10. Clin Ther. 2021. PMID: 33581877
-
Osmotherapy for elevated intracranial pressure: a critical reappraisal.Clin Pharmacokinet. 2000 Jan;38(1):23-40. doi: 10.2165/00003088-200038010-00002. Clin Pharmacokinet. 2000. PMID: 10668857 Review.
Cited by
-
In vivo and in vitro investigations of schisandrin B against angiotensin II induced ferroptosis and atrial fibrosis by regulation of the SIRT1 pathway.Sci Rep. 2025 Feb 20;15(1):6200. doi: 10.1038/s41598-025-89895-0. Sci Rep. 2025. PMID: 39979353 Free PMC article.
References
-
- Hartig S, Fries S, Balcarcel RR. Reduced mitochondrial membrane potential and metabolism correspond to acute chloroform toxicity of in vitro hepatocytes. J. Appl. Toxicol. 2005;25:310–317. - PubMed
-
- Berger S, Schurer L, Hartl R, Messmer K, et al. Reduction of post-traumatic intracranial hypertension by hypertonic/hyperoncotic saline/dextran and hypertonic Mannitol. Neurosurgery. 1995;37:98–107. - PubMed
-
- Biestro A, Alberti R, Galli R, Cancela M, et al. Osmotherapy for increased intracranial pressure: comparison between Mannitol and Glycerol. Acta Neurochirurgica (Wien) 1997;139:725–732. - PubMed
-
- Docci D, Berardi E. Buldrati. Mannitol induced renal failure. Nephron. 1994;68:141. - PubMed
-
- Freshman SP, Battistella FD, Matteucci M, Wisner DH. Hypertonic saline (7.5%) versus Mannitol: a comparison for treatment of acute head injuries. The Journal of Trauma. 1993;35:344–348. - PubMed
LinkOut - more resources
Full Text Sources